18 Mar 2019

hVIVO's Alex Mann making an oral presentation at ISRIV 1st Influenza Vaccine Group Meeting, Siena, Italy, March

Share this:

ISRIV 1st Influenza Vaccine Group Meeting, March 31st - April 2nd, Siena, Italy

Alex Man, hVIVO’s Director Clinical Science R&D Operations, will be making an oral presentation at ISRIV 1st Influenza Vaccine Group Meeting. The event takes place between March 31st and April 2nd in Siena, Italy.

Alex Mann, will be presenting on Sunday, March 31st:

‘Understanding Vaccine Correlates: The Human Influenza Challenge Model’ (Sunday, March 31st, Session B, 17:45).

If you would like to make contact with Alex Mann, Director Clinical Science R&D Operations, and Reid Tripp, Executive Vice President, Business Development and Marketing, from hVIVO before or during the ISIRV event in Siena, please use the Contact Us page on this site.

Other recent posts

A New Era in Respiratory Vaccines: The modRNA Breakthrough and the Power of Human Challenge Trials

Executive Summary As respiratory vaccines continue to impose significant burdens on healthcare systems around the world, vaccine development has entered a transformative era. This white paper explores the history of...

hLAB Corporate Factsheet

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.

Stay connected

Sign up to our emails and follow us on social media to keep up to date with hVIVO.

By clicking Sign Up you're confirming that you agree with our Privacy Policy.